Trial Profile
The study to investigate effects of ezetimibe on the changes in plasma incretins.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2013
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 30 Jun 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 08 Feb 2012 New trial record